Press Release Press Release Cardiac Dimensions Included in the New 2021 ESC Guidelines for Heart Failure Management Guidelines support the Carillon Mitral Contour System® for the treatment of heart failure patients with secondary functional mitral regurgitation...
Press Release Press Release Cardiac Dimensions® Announces Launch of Its Optimized U.S. Pivotal Trial – The EMPOWER Trial International Study to Evaluate Innovative Minimally Invasive Treatment for Heart Failure With Early-Stage Functional Mitral Regurgitation...
Press Release Press Release Cardiac Dimensions Announces Two New Meta-Analysis Publications Showing Statistically Significant and Clinically Meaningful Benefits to Heart Failure Patients Suffering from Functional Mitral Regurgitation KIRKLAND, WA – April 7, 2021 —...
Press Release Press Release Cardiac Dimensions Welcomes Robert White to its Board of Directors KIRKLAND, WA – April 6, 2021 — Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in...
Press Release Press Release Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System® Funds to be Used for Commercial Expansion in Europe and Australia KIRKLAND, WA – September 29, 2020 — Cardiac...
